1
|
Exopolysaccharides of Fungal Origin: Properties and Pharmaceutical Applications. Processes (Basel) 2023. [DOI: 10.3390/pr11020335] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/21/2023] Open
Abstract
Fungal exopolysaccharides (EPSs) represent an important group of bioactive compounds secreted by fungi. These biopolymers can be utilized individually or in combination with different bioactive substances for a broad range of pharmaceutical field applications, due to their various biological activities, such as antioxidant, antimicrobial, anti-inflammatory, antiviral, anti-diabetic, and anticoagulant effects. The paper presents an up-to-date review of the main fungal polysaccharides (pullulan, schizophyllan, scleroglucan, botryosphaeran, lentinan, grifolan, and lasiodiplodan), highlighting their structures, producing strains, and useful properties in a double position, as controlled release (rate and selectively targeting) drug carriers, but mostly as active immunomodulating and antitumor compounds in cancer therapy.
Collapse
|
2
|
Wouk J, Celestino GG, Rodrigues BCD, Malfatti CRM, Cunha MAA, Orsato A, Barbosa-Dekker AM, Dekker RFH, Lonni AASG, Reis Tavares E, Faccin-Galhardi LC. Sulfonated (1 → 6)-β-d-Glucan (Lasiodiplodan): A Promising Candidate against the Acyclovir-Resistant Herpes Simplex Virus Type 1 (HSV-1) Strain. Biomacromolecules 2022; 23:4041-4052. [PMID: 36173245 DOI: 10.1021/acs.biomac.2c00156] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
Abstract
Herpes simplex virus type 1 (HSV-1) is a persistent human pathogen, and the emergence of strains resistant to Acyclovir (ACV, reference drug) shows the urgency to develop new treatments. We report the antiherpetic mechanism of the action of lasiodiplodan (LAS-N, (1 → 6)-β-d-glucan) and its sulfonated derivative (LAS-S3) in vitro and in vivo. LAS-S3 showed anti-HSV-1 action with high selectivity indices for HSV-1 KOS (88.1) and AR (189.2), sensitive and resistant to ACV, respectively. LAS-S3 inhibited >80% of HSV-1 infection in different treatment protocols (virucidal, adsorption inhibition, and post-adsorption effects), even at low doses, and showed a preventive effect and DNA and protein synthesis inhibition. The antiherpetic effect was confirmed in vivo by the cosmetic LAS-S3-CRÈME decreasing cutaneous lesions of HSV-1, including the AR strain. LAS-S3 possessed a broad-spectrum mechanism of action acting in the early and post-adsorption stages of HSV-1 infection, and LAS-S3-CRÈME is a potential antiherpetic candidate for patients infected by HSV-1-resistant strains.
Collapse
Affiliation(s)
| | | | | | - Carlos R M Malfatti
- Programa de Pós-graduação em Ciências Farmacêuticas (PPGCF), Campus CEDETEG, Universidade Estadual do Centro-Oeste (UNICENTRO), Guarapuava 85040-167, Brazil
| | - Mário A A Cunha
- Departamento de Química, Universidade Tecnológica Federal do Paraná (UTFPR), Pato Branco 85503-390, Brazil
| | | | - Aneli M Barbosa-Dekker
- β-Glucan Produtos Farmoquímicos EIRELI, Lote 24A, Bloco Zircônia, Universidade Tecnológica Federal do Paraná, 731 Avenida João Miguel Caram, Londrina 86036-700, Brazil
| | - Robert F H Dekker
- β-Glucan Produtos Farmoquímicos EIRELI, Lote 24A, Bloco Zircônia, Universidade Tecnológica Federal do Paraná, 731 Avenida João Miguel Caram, Londrina 86036-700, Brazil
| | | | | | | |
Collapse
|
3
|
Nissola C, Marchioro MLK, de Souza Leite Mello EV, Guidi AC, de Medeiros DC, da Silva CG, de Mello JCP, Pereira EA, Barbosa-Dekker AM, Dekker RFH, Cunha MAA. Hydrogel containing (1 → 6)-β-D-glucan (lasiodiplodan) effectively promotes dermal wound healing. Int J Biol Macromol 2021; 183:316-330. [PMID: 33930443 DOI: 10.1016/j.ijbiomac.2021.04.169] [Citation(s) in RCA: 16] [Impact Index Per Article: 5.3] [Reference Citation Analysis] [Abstract] [Key Words] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/15/2020] [Revised: 04/23/2021] [Accepted: 04/25/2021] [Indexed: 11/24/2022]
Abstract
A hydrogel containing exocellular (1 → 6)-β-D-glucan (lasiodiplodan, LAS) was developed and its wound healing potential was evaluated. β-Glucans have attracted much interest by the cosmetic industry sector because of their bioactive and functional properties and in promoting skin health. In the present work an β-glucan was studied as a healing biomaterial that has not hitherto been reported in the scientific literature. LAS produced by the ascomycete Lasiodiplodia theobromae MMPI was used in the formulation of a healing hydrogel. Physicochemical and microbiological quality parameters, antioxidant potential and stability of the formulation was evaluated. FTIR, thermal analysis and SEM techniques were also employed in the characterization. Wistar rats were used as a biological model to investigate the wound healing potential. Histological analyses of cutaneous tissue from the dorsal region were conducted after 4, 7, 10 and 14 days of treatment, and evaluated re-epithelialization, cell proliferation and collagen production. Physicochemical stability, microbiological quality and antioxidant potential, especially in relation to its ability to scavenge hydroxyl radicals were found. The hydrogel stimulated cell re-epithelialization and proliferation during all days of the treatment, and stimulated an increase of collagen fibers. Lasiodiplodan showed immunomodulatory activity in wound healing and this biomacromolecule could be an alternative compound in wound care.
Collapse
Affiliation(s)
- Candida Nissola
- Programa de Pós-Graduação em Biotecnologia, Universidade Tecnológica Federal do Paraná, Câmpus Dois Vizinhos, CEP 85660-000 Dois Vizinhos, Paraná, Brazil
| | - Marcelo Luis Kuhn Marchioro
- Departamento de Química, Universidade Tecnológica Federal do Paraná, Campus Pato Branco, CEP 85503-390 Pato Branco, Paraná, Brazil
| | | | - Ana Carolina Guidi
- Departamento de Farmácia, Laboratório de Biologia Farmacêutica, Universidade Estadual de Maringá, CEP 87020-900 Maringá, Paraná, Brazil
| | - Daniela Cristina de Medeiros
- Departamento de Farmácia, Laboratório de Biologia Farmacêutica, Universidade Estadual de Maringá, CEP 87020-900 Maringá, Paraná, Brazil
| | - Camila Girotto da Silva
- Departamento de Farmácia, Laboratório de Biologia Farmacêutica, Universidade Estadual de Maringá, CEP 87020-900 Maringá, Paraná, Brazil
| | - João Carlos Palazzo de Mello
- Departamento de Farmácia, Laboratório de Biologia Farmacêutica, Universidade Estadual de Maringá, CEP 87020-900 Maringá, Paraná, Brazil
| | - Edimir Andrade Pereira
- Departamento de Química, Universidade Tecnológica Federal do Paraná, Campus Pato Branco, CEP 85503-390 Pato Branco, Paraná, Brazil
| | - Aneli M Barbosa-Dekker
- Departamento de Química, Centro de Ciências Exatas, Universidade Estadual de Londrina, CEP 86057-970 Londrina, Paraná, Brazil
| | - Robert F H Dekker
- Programa de Pós-Graduação em Engenharia Ambiental, Universidade Tecnológica Federal do Paraná, Câmpus Londrina, CEP 86036-370 Londrina, Paraná, Brazil
| | - Mário A A Cunha
- Programa de Pós-Graduação em Biotecnologia, Universidade Tecnológica Federal do Paraná, Câmpus Dois Vizinhos, CEP 85660-000 Dois Vizinhos, Paraná, Brazil; Departamento de Química, Universidade Tecnológica Federal do Paraná, Campus Pato Branco, CEP 85503-390 Pato Branco, Paraná, Brazil.
| |
Collapse
|
4
|
Wouk J, Dekker RFH, Queiroz EAIF, Barbosa-Dekker AM. β-Glucans as a panacea for a healthy heart? Their roles in preventing and treating cardiovascular diseases. Int J Biol Macromol 2021; 177:176-203. [PMID: 33609583 DOI: 10.1016/j.ijbiomac.2021.02.087] [Citation(s) in RCA: 20] [Impact Index Per Article: 6.7] [Reference Citation Analysis] [Abstract] [Key Words] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/23/2020] [Revised: 02/04/2021] [Accepted: 02/12/2021] [Indexed: 02/07/2023]
Abstract
Cardiovascular diseases (CVDs) are the leading cause of death worldwide. Factors increasing the risks for CVD development are related to obesity, diabetes, high blood cholesterol, high blood pressure and lifestyle. CVD risk factors may be treated with appropriate drugs, but prolonged can use cause undesirable side-effects. Among the natural products used in complementary and alternative medicines, are the β-ᴅ-glucans; biopolymers found in foods (cereals, mushrooms), and can easily be produced by microbial fermentation. Independent of source, β-glucans of the mixed-linked types [(1 → 3)(1 → 6)-β-ᴅ-glucans - fungal, and (1 → 3)(1 → 4)-β-ᴅ-glucans - cereal] have widely been studied because of their biological activities, and have demonstrated cardiovascular protective effects. In this review, we discuss the roles of β-ᴅ-glucans in various pathophysiological conditions that lead to CVDs including obesity, dyslipidemia, hyperglycemia, oxidative stress, hypertension, atherosclerosis and stroke. The β-glucans from all of the sources cited demonstrated potential hypoglycemic, hypocholesterolemic and anti-obesogenicity activities, reduced hypertension and ameliorated the atherosclerosis condition. More recently, β-glucans are recognized as possessing prebiotic properties that modulate the gut microbiome and impact on the health benefits including cardiovascular. Overall, all the studies investigated unequivocally demonstrated the dietary benefits of consuming β-glucans regardless of source, thus constituting a promising panaceutical approach to reduce CVD risk factors.
Collapse
Affiliation(s)
- Jéssica Wouk
- Programa de Pós-graduação em Ciências Farmacêuticas, Universidade Estadual do Centro-Oeste, Campus CEDETEG, CEP: 85040-167, Guarapuava, Paraná, Brazil
| | - Robert F H Dekker
- Universidade Tecnológica Federal do Paraná, Programa de Pós-Graduação em Engenharia Ambiental, Câmpus Londrina, CEP: 86036-370 Londrina, Paraná, Brazil; Beta-Glucan Produtos Farmoquímicos - EIRELI, Avenida João Miguel Caram 731, Lote 24(A), Bloco Zircônia, Universidade Tecnológica Federal do Paraná, CEP: 86036-700 Londrina, Paraná, Brazil.
| | - Eveline A I F Queiroz
- Núcleo de Pesquisa e Apoio Didático em Saúde, Instituto de Ciências da Saúde, Câmpus Universitário de Sinop, Universidade Federal de Mato Grosso, CEP: 78.557-267 Sinop, Mato Grosso, Brazil
| | - Aneli M Barbosa-Dekker
- Beta-Glucan Produtos Farmoquímicos - EIRELI, Avenida João Miguel Caram 731, Lote 24(A), Bloco Zircônia, Universidade Tecnológica Federal do Paraná, CEP: 86036-700 Londrina, Paraná, Brazil
| |
Collapse
|
5
|
de Sales Guilarducci J, Marcelino BAR, Konig IFM, Orlando TM, Varaschin MS, Pereira LJ. Therapeutic effects of different doses of prebiotic (isolated from S accharomyces cerevisiae) in comparison to n-3 supplement on glycemic control, lipid profiles and immunological response in diabetic rats. Diabetol Metab Syndr 2020; 12:69. [PMID: 32793305 PMCID: PMC7418400 DOI: 10.1186/s13098-020-00576-6] [Citation(s) in RCA: 8] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 05/21/2020] [Accepted: 08/01/2020] [Indexed: 02/08/2023] Open
Abstract
BACKGROUND The regular intake of fiber generates numerous health benefits. However, the efficacy depends on the duration of consumption and the ingested dose. Studies investigating the optimal dose are of interest to enable the inclusion of fiber in the routine treatment of diabetic patients. OBJECTIVE We aimed to evaluate the effects of different doses of β-glucan (BG-isolated from Saccharomyces cerevisiae), in comparison to n-3 supplement, on the inflammatory and metabolic parameters of Wistar rats induced to diabetes by streptozotocin. METHODS Forty animals were randomly divided into six groups receiving 0 mg/kg, 10 mg/kg, 20 mg/kg, or 40 mg/kg BG daily for 4 weeks or fish oil derivative [1000 mg/kg of omega-3 fatty acids (n-3)] for the same period. One additional group was composed of healthy controls. Serum metabolic and immunological parameters were evaluated by colorimetric and ELISA assays respectively. Histopathological analysis of the liver, small intestine and pancreas were also conducted. Significant changes due to BG intake were set into regression models with second-degree fit in order to estimate the optimal BG dose to achieve health benefits. RESULTS The animals that ingested BG had lower food and water intake (p < 0.05) than the negative control group (0 mg/kg). However, consumption was still elevated in comparison to healthy controls. Blood glucose and serum levels of total cholesterol, LDL-c, and TG (p < 0.05) reduced in comparison to diabetic animals without treatment (better or similar to n-3 group depending on dose), but did not reach normal levels (in comparison to healthy controls). HDL-c was not different (p > 0.05) among all groups. These reductions were already seen with the lowest dose of 10 mg/kg. On average, the serum levels of the hepatic enzymes ALT and AST were 40% and 60% lower in the BG groups in comparison to diabetic animals without treatment (better results than n-3 group). The group receiving 40 mg/kg reached similar values of healthy controls for ALT; whereas the same result occurred from the dose of 10 mg/kg for AST. The ideal dose, estimated from the mean of all metabolic parameters was approximately 30 mg/kg/day. Regarding the immunological profile, TNF-α significantly decreased in the BG groups compared to controls (p < 0.05), reaching better values than n-3 group and similar to healthy controls. No significant differences were found between the groups in IL-1β or IL-10 (p > 0.05). No histological changes were found in the pancreas, liver, or intestine due to treatment among diabetic animals. CONCLUSIONS BG significantly reduced blood glucose as well as serum total cholesterol, LDL-c and TG. There was a hepatoprotective effect due to the reduction in ALT and AST and a reduction in TNF-α, indicating a modulation of the immune response. In general, BG effects were better than n-3 supplement (or at least comparable) depending on the dose.
Collapse
Affiliation(s)
- Janina de Sales Guilarducci
- Departamento de Ciências da Saúde – DSA, Universidade Federal de Lavras – UFLA, 3037, Lavras, 37200-000 Brazil
| | | | - Isaac Filipe Moreira Konig
- Departamento de Ciências da Saúde – DSA, Universidade Federal de Lavras – UFLA, 3037, Lavras, 37200-000 Brazil
| | - Tamira Maria Orlando
- Departamento de Ciências da Saúde – DSA, Universidade Federal de Lavras – UFLA, 3037, Lavras, 37200-000 Brazil
| | - Mary Suzan Varaschin
- Departamento de Ciências da Saúde – DSA, Universidade Federal de Lavras – UFLA, 3037, Lavras, 37200-000 Brazil
- Departamente de Medicina Veterinária – DMV, Universidade Federal de Lavras – UFLA, 3037, Lavras, 37200-000 Brazil
| | - Luciano José Pereira
- Departamento de Ciências da Saúde – DSA, Universidade Federal de Lavras – UFLA, 3037, Lavras, 37200-000 Brazil
| |
Collapse
|
6
|
Malfatti CRM, dos Santos FS, Wouk J, da Silva LA, Michel RG, Snak AL, Czervinski T, da Cunha MAA, Barbosa AM, Dekker RFH. Intracerebroventricular administration of the (1→6)-β-d-glucan (lasiodiplodan) in male rats prevents d-penicillamine-induced behavioral alterations and lipoperoxidation in the cortex. PHARMACEUTICAL BIOLOGY 2017; 55:1289-1294. [PMID: 28274189 PMCID: PMC6130678 DOI: 10.1080/13880209.2017.1299767] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 11/03/2015] [Revised: 12/02/2016] [Accepted: 02/21/2017] [Indexed: 05/31/2023]
Abstract
CONTEXT Lasiodiplodan, an exocellular (1→6)-β-d-glucan of molecular weight >1.4 × 106 Da produced by MMPI strain of Lasiodiplodia theobromae (Pat.) Griffon & Maubl. (Brotyosphaeriaceae) is known to exhibit anti-proliferative activity on breast cancer cells (MCF-7), anticoagulant activity when sulfonylated, and reduction in transaminase activity when administered in rats. OBJECTIVE The effect of intracerebroventricular (I.C.V) injection of lasiodiplodan on neurotoxicity and behavioural changes induced by d-penicillamine was investigated. MATERIALS AND METHODS Twenty-four male Wistar rats were initially separated in groups of six and treated with 0.15 μmol/μL of NaCl (Groups Ct and d-Pen) and 0.01 μg/μL of lasiodiplodan (Groups Las and Las + d-Pen). After 15 min, they received 6 μmol/μL of NaCl (Groups Ct and Las) and 2 μmol/μL of d-penicillamine (Groups d-Pen and Las + d-Pen). The animal behavior was observed in an open-field test for 60 min. Twenty-four h later, the animals were sacrificed and histopathological analysis and Thiobarbituric acid reactive substances (TBARS) production measurements were performed. RESULTS Lasiodiplodan prevented neurotoxicity induced by d-penicillamine significantly reducing the production of TBARS (308%; p < 0.05), and behavioural signs; convulsive and pre-convulsive. No histopathological alterations in the cerebral cortex were observed. DISCUSSION AND CONCLUSION The reduction of TBARS production and convulsive episodes suggests that the protector effect provided by lasiodiplodan passes thought an antioxidant path, possibly interfering in a cascade of neurochemical events, triggering cell death and convulsive episodes. These results demonstrated that lasiodiplodan can be effective in treating neurotoxicity, and reducing damage triggered by convulsions in neuropathies related to GABAergic system.
Collapse
Affiliation(s)
| | - Fabio Seidel dos Santos
- Teaching of Science and Technology Postgraduate Program, Federal Technological University of Paraná, Campus Ponta Grossa, Ponta Grossa, Brazil
| | - Jéssica Wouk
- Pharmaceutical Science Postgraduate Program, Midwest State University, Campus CEDETEG, Guarapuava, Brazil
| | - Luiz Augusto da Silva
- Pharmaceutical Science Postgraduate Program, Midwest State University, Campus CEDETEG, Guarapuava, Brazil
| | - Renan Garcia Michel
- Pharmaceutical Science Postgraduate Program, Midwest State University, Campus CEDETEG, Guarapuava, Brazil
| | - André Luiz Snak
- Pharmaceutical Science Postgraduate Program, Midwest State University, Campus CEDETEG, Guarapuava, Brazil
| | - Tiago Czervinski
- Pharmaceutical Science Postgraduate Program, Midwest State University, Campus CEDETEG, Guarapuava, Brazil
| | - Mário A. Alves da Cunha
- Department of Chemistry, Federal Technological University of Paraná, Campus Pato branco, Pato Branco, Brazil
| | - Aneli M. Barbosa
- Department of Chemistry, Londrina State University, Londrina, Brazil
| | - Robert F. H. Dekker
- Environmental Engineering Postgraduate Program, Federal Technological University of Paraná, Campus Londrina, Londrina, Brazil
| |
Collapse
|
7
|
Mello MB, Machado CS, Ribeiro DL, Aissa AF, Burim RV, Alves da Cunha MA, Barcelos GRM, Antunes LMG, Bianchi MLP. Protective effects of the exopolysaccharide Lasiodiplodan against DNA damage and inflammation induced by doxorubicin in rats: Cytogenetic and gene expression assays. Toxicology 2016; 376:66-74. [PMID: 27181935 DOI: 10.1016/j.tox.2016.05.010] [Citation(s) in RCA: 16] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Abstract] [Key Words] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/20/2015] [Revised: 05/06/2016] [Accepted: 05/12/2016] [Indexed: 12/29/2022]
Abstract
The lasiodiplodan (LS) is a β-(1→6)-d-glucan produced by the fungus Lasiodiplodia theobromae and some of the biological activities of LS were reported as hypoglycemic, anticoagulant, anti-proliferative and anticancer action; however, its effects on DNA instability and modulation of gene expression are still unclear. Aims of study were investigate the genotoxic effects of lasiodiplodan, and its protective activity against DNA damage induced by doxorubicin (DXR) and its impact on the expression of genes associated with DNA damage and inflammatory response pathways. Therefore, Wistar rats were treated (15 days) orally with LS (5.0; 10 and 20mg/kg bw) alone and in combination with DXR (15mg/kg bw; administrated intraperitoneally on 14th day) as well as their respective controls: distilled water and DXR. Monitoring of DNA damage was assessed by comet and micronucleus (MN) assays and gene expression was evaluated by PCR-Arrays. Treatments with LS alone did not induce disturbances on DNA; when LS was given in combination with DXR, comet and MN formations were reduced to those found in the respective controls. Moreover, LS was able to reduce the disturbances on gene expressions induced by DXR treatment, since the animals that receive LS associated with DXR showed no alteration in the expression of genes related to DNA damage response. Also, DXR induced several up- and down-regulation of several genes associated to inflammatory process, while the animals that received LS+DXR had their gene expression patterns similar to those found in the control group. In conclusion, our results showed that LS did not induce disturbances on DNA stability and significantly reduce the DNA damage and inflammation caused by DXR exposure. In addition, we give further information concerning the molecular mechanisms associated to LS protective effects which seems to be a promising nutraceutical with chemopreventive potential.
Collapse
Affiliation(s)
- M B Mello
- Department of Clinical Analyses, Toxicology and Food Sciences, School of Pharmaceutical Sciences of Ribeirão Preto, University of São Paulo, Avenida do Café s/n°, CEP 14040-903, Ribeirão Preto, São Paulo, Brazil
| | - C S Machado
- Department of Genetics; School of Medicine of Ribeirão Preto, University of São Paulo, Avenida Bandeirantes, 3900, CEP 14049-900, Ribeirão Preto, São Paulo, Brazil
| | - D L Ribeiro
- Department of Genetics; School of Medicine of Ribeirão Preto, University of São Paulo, Avenida Bandeirantes, 3900, CEP 14049-900, Ribeirão Preto, São Paulo, Brazil
| | - A F Aissa
- Department of Clinical Analyses, Toxicology and Food Sciences, School of Pharmaceutical Sciences of Ribeirão Preto, University of São Paulo, Avenida do Café s/n°, CEP 14040-903, Ribeirão Preto, São Paulo, Brazil
| | - R V Burim
- Department of Clinical Analyses, Toxicology and Food Sciences, School of Pharmaceutical Sciences of Ribeirão Preto, University of São Paulo, Avenida do Café s/n°, CEP 14040-903, Ribeirão Preto, São Paulo, Brazil
| | - M A Alves da Cunha
- Department of Chemistry, Federal University of Technology of Paraná, Via do Conhecimento, km 01, CEP 85503-390, Pato Branco, Paraná, Brazil
| | - G R M Barcelos
- Department of Clinical Analyses, Toxicology and Food Sciences, School of Pharmaceutical Sciences of Ribeirão Preto, University of São Paulo, Avenida do Café s/n°, CEP 14040-903, Ribeirão Preto, São Paulo, Brazil; Department of Biosciences, Institute of Health and Society, Federal University of São Paulo, Rua Silva Jardim, 136, CEP 11015-020, Santos, São Paulo, Brazil.
| | - L M G Antunes
- Department of Clinical Analyses, Toxicology and Food Sciences, School of Pharmaceutical Sciences of Ribeirão Preto, University of São Paulo, Avenida do Café s/n°, CEP 14040-903, Ribeirão Preto, São Paulo, Brazil
| | - M L P Bianchi
- Department of Clinical Analyses, Toxicology and Food Sciences, School of Pharmaceutical Sciences of Ribeirão Preto, University of São Paulo, Avenida do Café s/n°, CEP 14040-903, Ribeirão Preto, São Paulo, Brazil
| |
Collapse
|
8
|
|
9
|
|